Grant Karno, MD
Pain Medicine · Las Vegas, NVNPI 1124462056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 88.1% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for pain medicine clinicians in NV, where the typical reported total is $2,557.
Across 114 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Curonix LLC$155
- Boston Scientific$73
What the payments were for
- Food & beverage$1,917100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 108 | $1,689 |
| Curonix LLC | 4 | $155 |
| Boston Scientific | 2 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$114
How this compares
$1,917 in reported general payments places this provider in the 40th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $15,938 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 237 | $9,655 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 220 | $5,022 |
| Oxycodone Hcl | 123 | $2,620 |
| Gabapentin | 227 | $2,414 |
| Pregabalin | 104 | $1,551 |
| Lidocaine | 16 | $1,325 |
| Tizanidine Hcl | 184 | $1,298 |
| Methocarbamol | 93 | $1,069 |
| Diclofenac Sodium | 76 | $931 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $819 |
| Celecoxib | 22 | $807 |
| Ibuprofen | 64 | $720 |
| Cephalexin | 65 | $714 |
| Duloxetine Hcl | 44 | $491 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.